Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Decitabine (DACOGEN) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Sulindac for Patients With AML
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients
- Status
- COMPLETED
- Phase
- PHASE2
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GRASPA Treatment for Patients With Acute Myeloblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE2
Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML
- Status
- TERMINATED
- Phase
- PHASE2
Mismatched Donor Cells to Treat Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
- Status
- UNKNOWN
- Phase
- N/A
GVAX vs. Placebo for MDS/AML After Allo HSCT
- Status
- TERMINATED
- Phase
- PHASE2